IP Library Granted Patent US 10,955,322
Granted Patent B2
US 10,955,322 · App. 15/874,673 · Granted Mar 23, 2021

Methods and devices for soft and osseous tissue clearing and fluorescent imaging

Inventors: Viviana Gradinaru (La Canada-Flintridge, CA); Ken Y. Chan (Pasadena, CA); Alon Grinbaum (West Hollywood, CA)
Assignee: California Institute of Technology
G01N1/30A61K35/32G01N1/34G01N1/36G01N2001/302G01N2001/364
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,955,322
App. No.
15/874,673
Granted
Mar 23, 2021
Kind
B2
Abstract

Described herein is a bone tissue clearing method with enhanced optical access. Compositions and techniques for bone tissue clearing include continuous convective flow during the clearing process, amino alcohol to minimize tissue autofluorescence, and an imaging procedure that minimizes refractive index variations in light-sheet microscopy. These improvements allowed the Inventors to achieve whole-bone clearing with an imaging depth of up to about 1.5 mm while maintaining fluorescence and a signal-to-noise ratio (SNR) that permits detection and 3D placement of single cells. In various embodiments, the present application teaches methods and kits for clearing and optionally subsequently visualizing tissue containing bone.

Claims (41)

1. A method, comprising:

fixing a bone tissue sample by applying a fixative solution to generate a fixed bone tissue sample;

decalcifying the fixed bone tissue sample by applying a decalcifying solution comprising a calcium chelating agent to generate a decalcified bone tissue sample;

stabilizing the decalcified bone tissue sample by applying a hydrogel monomer solution;

initiating polymerization of the monomer solution to generate a decalcified bone tissue sample hydrogel matrix;

washing the decalcified bone tissue sample hydrogel matrix;

removing lipids from the washed decalcified bone tissue sample hydrogel matrix by applying a detergent solution to generate a substantially cleared bone tissue sample;

removing heme from the substantially cleared bone tissue sample by applying a removal solution comprising an amino alcohol to generate a cleared bone tissue sample;

further washing the cleared bone tissue sample;

serially applying refractive index matching solutions (RIMS) with progressively higher refractive indexes (RIs) to the cleared bone tissue sample; and

using a microscope to visualize the tissue comprising the bone tissue sample comprising bone and bone marrow of the subject that has been incubated in the final RIMS at an imaging depth below 200 mm.

2. The method of claim 1 , wherein the fixative solution comprises 2-6% paraformaldehyde (PFA).

3. The method of claim 2 , wherein the fixative solution comprises 4% PFA.

4. The method of claim 1 , wherein the calcium chelating agent comprises ethylenediaminetetraacetic acid (EDTA).

5. The method of claim 1 , wherein the hydrogel monomer solution comprises 2-8% acrylamide.

6. The method of claim 5 , wherein the hydrogel monomer solution comprises 4% acrylamide.

7. The method of claim 1 , further comprising

placing the decalcified bone tissue sample into a substantially air tight chamber, and introducing nitrogen into the substantially air tight chamber.

8. The method of claim 1 , wherein the hydrogel monomer solution comprises a thermoinitiator or photoinitiator.

9. The method of claim 1 , wherein the detergent solution comprises 6-15% sodium dodecyl sulfate (SDS).

10. The method of claim 9 , wherein the detergent solution comprises 8% SDS.

11. The method of claim 1 , wherein the removal solution comprising the amino alcohol comprises N,N,N′,N′-Tetrakis(2-Hydroxypropyl)ethylenediamine.

12. The method of claim 11 , wherein the removal solution comprises 25% N,N,N′,N′-Tetrakis(2-Hydroxypropyl)ethylenediamine.

13. The method of claim 1 , wherein a first RIMS in which the tissue comprising the bone of the subject is incubated has an RI of 1.36-1.40.

14. The method of claim 13 , wherein a second RIMS in which the tissue comprising bone is incubated has an RI of 1.41-1.45.

15. The method of claim 14 , wherein the tissue comprising bone is incubated in a third RIMS that has an RI of 1.45-1.47.

16. The method of claim 1 , wherein stirring, flow assistance or constant flow is introduced for one or more steps of: applying a decalcifying solution, applying a hydrogel monomer solution, washing the decalcified bone tissue sample hydrogel matrix, applying a detergent solution to generate a substantially cleared bone tissue sample, applying a removal solution, and further washing the cleared bone tissue sample.

17. The method of claim 1 , wherein the microscope is a light sheet microscope.

18. A method comprising:

fixing a bone tissue sample by applying a fixative solution comprising 4% paraformaldehyde (PFA) to generate a fixed bone tissue sample;

decalcifying a fixed bone tissue sample by applying a decalcifying solution comprising ethylenediaminetetraacetic acid (EDTA) and stirring to generate a decalcified bone tissue sample;

stabilizing the decalcified bone tissue sample by applying a hydrogel monomer solution comprising 4% acrylamide with flow assistance;

initiating polymerization of the monomer solution to generate a decalcified bone tissue sample hydrogel matrix;

washing the decalcified bone tissue sample hydrogel matrix with flow assistance;

removing lipids from the washed decalcified bone tissue sample hydrogel matrix by applying a detergent solution comprising 8% sodium dodecyl sulfate (SDS) with flow assistance to generate a substantially cleared bone tissue sample;

removing heme from the substantially cleared bone tissue sample by applying a removal solution comprising 25% N,N,N′,N′-Tetrakis(2-Hydroxypropyl)ethylenediamine with flow assistance to generate a cleared bone tissue sample;

further washing the cleared bone tissue sample with constant stirring;

serially applying refractive index matching solutions (RIMS) with progressively higher refractive indexes (RIs) to the cleared bone tissue sample; and

using a microscope to visualize the bone tissue sample comprising bone and bone marrow of the subject that has been incubated in the final RIMS at an imaging depth below 200 mm.

19. The method of claim 1 , wherein the imaging depth is below 100 mm.

20. The method of claim 18 , wherein the imaging depth is below 100 mm.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2021
From: HERITAGE MEDICAL RESEARCH INSTITUTE (HMRI)
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 055825/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2018
From: GRADINARU, VIVIANA
To: CALIFORNIA INSTITUTE OF TECHNOLOGY; HERITAGE MEDICAL RESEARCH INSTITUTE
Reel/Frame 046499/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2018
From: GRINBAUM, ALON; CHAN, KEN Y.
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 046499/0662 →
CONFIRMATORY LICENSE Recorded Mar 15, 2018
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045217/0913 →
Continuity (2)
Provisional Application 62447781 · Jan 18, 2017
Related Publication 20180202904A1 · Jul 19, 2018